Evidence map›Paper›PMID 36084257›Full record

ArticleAdvanced biology2022

Extracellular Matrix Modulates Outgrowth Dynamics in Ovarian Cancer.

Sarah Alshehri, Tonja Pavlovič, Sadaf Farsinejad, Panteha Behboodi, Li Quan, Daniel Centeno, Douglas Kung, Marta Rezler, Woo Lee, Piotr Jasiński and 5 more

Open access · greenAbstract read
In one paragraph

Article in Advanced biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Journal of biomedical optics · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 2 countries.

Sarah AlshehriDepartment of Chemistry and Chemical Biology, Stevens Institute of Technology, 1 Castle Point Terrace, Hoboken, NJ, 07030, USA.ORCID 0000-0002-1080-7524
Tonja PavlovičDepartment of Chemistry and Chemical Biology, Stevens Institute of Technology, 1 Castle Point Terrace, Hoboken, NJ, 07030, USA.ORCID 0000-0002-1165-4013
Sadaf FarsinejadDepartment of Chemistry and Chemical Biology, Stevens Institute of Technology, 1 Castle Point Terrace, Hoboken, NJ, 07030, USA.
Panteha BehboodiDepartment of Chemical Engineering, Stevens Institute of Technology, 1 Castle Point Terrace, Hoboken, NJ, 07030, USA.
Li QuanDepartment of Chemical Engineering, Stevens Institute of Technology, 1 Castle Point Terrace, Hoboken, NJ, 07030, USA.
Daniel CentenoDepartment of Chemistry and Chemical Biology, Stevens Institute of Technology, 1 Castle Point Terrace, Hoboken, NJ, 07030, USA.
Douglas KungDepartment of Chemistry and Chemical Biology, Stevens Institute of Technology, 1 Castle Point Terrace, Hoboken, NJ, 07030, USA.
Marta RezlerPoznań University of Medical Sciences, Collegium Maius, Fredry 10, Poznań, 61-701, Poland.
Woo LeeDepartment of Chemistry and Chemical Biology, Stevens Institute of Technology, 1 Castle Point Terrace, Hoboken, NJ, 07030, USA.
Piotr JasińskiDepartment of Pathology, Poznań University of Medical Sciences, Polna 33, Poznań, 60-535, Poland.
Elżbieta DziabaszewskaDepartment of Pathology, Poznań University of Medical Sciences, Polna 33, Poznań, 60-535, Poland.
Ewa Nowak-MarkwitzDepartment of Gynecology, Obstetrics and Gynecologic Oncology, Poznań University of Medical Sciences, Polna 33, Poznań, 60-535, Poland.
Dilhan KalyonDepartment of Chemical Engineering, Stevens Institute of Technology, 1 Castle Point Terrace, Hoboken, NJ, 07030, USA.
Mikołaj P ZaborowskiDepartment of Gynecology, Obstetrics and Gynecologic Oncology, Poznań University of Medical Sciences, Polna 33, Poznań, 60-535, Poland.
Marcin IwanickiDepartment of Chemistry and Chemical Biology, Stevens Institute of Technology, 1 Castle Point Terrace, Hoboken, NJ, 07030, USA.ORCID 0000-0001-8375-8447
Stevens Institute of Technology · USPoznan University of Medical Sciences · PL

Funding

High-Resolution Dynamic Imaging of Ovarian Cancer Metastasis Post ChemotherapyR21CA256615 · NCI · THE TRUSTEES OF THE STEVENS INSTITUTE OF TECHNOLOGY · PI IWANICKI, MARCIN, WANG, SHANG · 2021 to 2022
$417k
NCI NIH HHS R21 CA256615
6 · The paper itself

Abstract

Ovarian carcinoma (OC) forms outgrowths that extend from the outer surface of an afflicted organ into the peritoneum. OC outgrowth formation is poorly understood due to the limited availability of cell culture models examining the behavior of cells that form outgrowths. Prompted by immunochemical evaluation of extracellular matrix (ECM) components in human tissues, laminin and collagen-rich ECM-reconstituted cell culture models amenable to studies of cell clusters that can form outgrowths are developed. It is demonstrated that ECM promotes outgrowth formation in fallopian tube non-ciliated epithelial cells (FNE) expressing mutant p53 and various OC cell lines. Outgrowths are initiated by cells that underwent outward translocation and retained the ability to intercalate into mesothelial cell monolayers. Electron microscopy, optical coherence tomography, and small amplitude oscillatory shear experiments reveal that increased ECM levels led to increased fibrous network thickness and high shear elasticity of the microenvironment. These physical characteristics are associated with outgrowth suppression. The low ECM microenvironment mimicks the viscoelasticity of malignant peritoneal fluid (ascites) and supports cell proliferation, cell translocation, and outgrowth formation. These results highlight the importance of the ECM microenvironment in modulating OC growth and can provide additional insights into the mode of dissemination of primary and recurrent ovarian tumors.

Indexed as

CarcinomaOvarian NeoplasmsCarcinoma, Ovarian EpithelialExtracellular MatrixFemaleHumansLamininNeoplasm Recurrence, LocalTumor MicroenvironmentLamininascitescollagenextracellular matrixlaminin γ1outgrowthsovarian cancertumor microenvironment

Identifiers

PMID36084257
PMCPMC9772079
OpenAlexW4295298938

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.